About the Programme:
The course will give knowledge about Pharmacovigilance and Intellectual Property Rights.
Improved patient safety and health outcomes through the identification and management of adverse drug reactions (ADRs).
Enhanced regulatory compliance and adherence to pharmacovigilance guidelines and regulations and improved understanding of the safety and efficacy of drugs and their risks and benefits
Identification of new safety concerns or risks associated with drugs and other medical products and improved public health through the timely detection and management of safety issues and protection of pharmaceutical companies’ investment in research and development
Encouragement of innovation and the development of new drugs and medical products and increased revenue and market share through the commercialization of patented drugs
When implemented together, Pharmacovigilance and IPR programs can work synergistically to improve patient safety while also promoting innovation and investment in the pharmaceutical industry. For example, Pharmacovigilance data can be used to support patent applications and defend against patent infringement claims, while patent protection can facilitate the commercialization of innovative drugs and medical products.
Objectives of the program:
- The main objective of pharmacovigilance is to monitor the safety of medicines and vaccines throughout their life cycle, from pre-market clinical trials to post-market surveillance.
- The goal is to identify and minimize the risks associated with the use of medicines, and to ensure that their benefits outweigh their potential harms.
- Both pharmacovigilance and IPRs have the ultimate goal of promoting public health by ensuring the availability of safe and effective medicines.
- Encouraging innovation by identifying potential safety issues early on in the development process.
- Both pharmacovigilance and IPRs seek to balance public health concerns with commercial interests, ensuring that innovative medicines are developed while also minimizing risks to public health.
Topics to be covered:
- Safety monitoring of medicines
- Intellectual property protection for pharmaceuticals
- Data exclusivity
- Patent law and pharmacovigilance
- Patentability and patent infringement
- Risk management plans
Programme Committee:
Chief Patron
Chairman
Dr. P. Rajeshwar Reddy,
M.Sc, Ph.D.
Secretary and Correspondent
Patron
Dr. M. Chinna Eswaraiah,
M. Pharm, Ph.D.
Principal
Convener
Mr. K. Raveendra Babu
M. Pharm,
Assistant Professor
Department of Pharmacy Practice
Email ID: ravipharma36@gmail.com
Contact number: 99592 12028
Coordinator
Mr. T. Praveen Kumar
M. Pharm,
Assistant Professor,
Department of Pharmaceutics,
Email ID: praveensuri1@gmail.com
Contact number: 9100337332
Resource Person:
Mrs. N. Amani,
M. Pharm,
Assistant Professor,
Department of Pharmacology,
Madhira Institute of Technology & Sciences, Kodad, Telangana.
Email ID: amaninukabathini@gmail.com
Contact number: 8106087459
Address for Communication:
Mr. T. Praveen Kumar
M. Pharm,
Assistant Professor,
Department of Pharmaceutics,
Email ID: praveensuri1@gmail.com
Contact number: 9100337332
Last date to Registration: 23/01/2022
0 Comments